Carlsmed (CARL) Change in Receivables (2024 - 2026)

Carlsmed has reported Change in Receivables for 3 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 6.9% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (changed N/A YoY), and the FY2025 full-year result was $5.0 million, up 26.23% from the prior year.
• Change in Receivables for Q1 2026 stood at $1.3 million, up from $117000.0 in the prior quarter.
• The five-year high for Change in Receivables was $1.9 million in Q2 2025, with the low at $98000.0 in Q3 2024.
• Historically, Change in Receivables has averaged $1.1 million across 3 years, with a median of $1.4 million in 2025.
• The largest YoY upside for Change in Receivables was 1543.88% in 2025 against a maximum downside of 92.64% in 2025.
• Carlsmed's Change in Receivables stood at $1.6 million in 2024, then tumbled by 92.64% to $117000.0 in 2025, then surged by 1017.95% to $1.3 million in 2026.
• The last three Change in Receivables figures came in at $1.3 million (Q1 2026), $117000.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.